ATP increases intracellular calcium in supraoptic neurons by activation of both P2X and P2Y purinergic receptors

被引:38
作者
Song, Zhilin [1 ]
Vijayaraghavan, Sukumar [1 ]
Sladek, Celia D. [1 ]
机构
[1] Univ Colorado Denver & Hlth Sci Ctr, Dept Physiol & Biophys, Aurora, CO 80045 USA
关键词
calcium imaging; fura-2 acetoxymethyl ester; thapsigargin; pyridoxal-phosphate-6-azophenyl-2; 4 '-disulphonic acid; cadmium; NEUROSECRETORY-CELLS; VASOPRESSIN CELLS; GASTRIN RECEPTOR; RAT; SECRETION; RELEASE; PURINOCEPTORS; STIMULATION; EXPRESSION; CHANNELS;
D O I
10.1152/ajpregu.00495.2006
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
ATP increases intracellular calcium concentration ([Ca2+](i)) in supraoptic nucleus (SON) neurons in hypothalamo-neurohypophyseal system explants loaded with the Ca2+-sensitive dye, fura 2-AM. Involvement of P2X purinergic receptors (P2XR) in this response was anticipated, because ATP stimulation of vasopressin release from hypothalamo-neurohypophyseal system explants required activation of P2XRs, and activation of P2XRs induced an increase in [Ca2+](i) in dissociated SON neurons. However, the ATP-induced increase in [Ca2+](i) persisted after removal of Ca2+ from the perifusate ([Ca2+](o)). This suggested involvement of P2Y purinergic receptors (P2YR), because P2YRs induce Ca2+ release from intracellular stores, whereas P2XRs are Ca2+-permeable ion channels. Depletion of [Ca2+](i) stores with thapsigargin (TG) prevented the ATP-induced increase in [Ca2+](i) in zero, but not in 2 mM [Ca2+](o), indicating that both Ca2+ influx and release of intracellular Ca2+ contribute to the ATP response. Ca2+ influx was partially blocked by cadmium, indicating a contribution of voltage-gated Ca2+ channels. PPADS (pyridoxal-phosphate-6-azophenyl-2',4'-disulphonic acid), and iso-PPADS, P2XR antagonists, attenuated, but did not abolish, the ATP-induced increase in [Ca2+](i). Combined treatment with PPADS or iso-PPADS and TG prevented the response. A cocktail of P2YR agonists consisting of UTP, UDP, and 2-methylthio-ADP increased [Ca2+](i) (with or without tetrodotoxin) that was markedly attenuated by TG. 2-Methylthio-ADP alone induced consistent and larger increases in [Ca2+](i) than UTP or UDP. MRS2179, a specific P2Y(1)R antagonist, eliminated the response to ATP in zero [Ca2+](o). Thus, both P2XR and P2YR participate in the ATP-induced increase in [Ca2+](i), and the P2Y(1)R subtype is more prominent than P2Y(2)R, P2Y(4)R, or P2Y(6)R in SON.
引用
收藏
页码:R423 / R431
页数:9
相关论文
共 26 条
[1]   Plasma and intracellular membrane inositol 1,4,5-trisphosphate receptors mediate the Ca2+ increase associated with the ATP-induced increase in ciliary beat frequency [J].
Barrera, NP ;
Morales, B ;
Villalón, M .
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2004, 287 (04) :C1114-C1124
[2]   Competitive and selective antagonism of P2Y1 receptors by N6-methyl 2′-deoxyadenosine 3′,5′-bisphosphate [J].
Boyer, JL ;
Mohanram, A ;
Camaioni, E ;
Jacobson, KA ;
Harden, TK .
BRITISH JOURNAL OF PHARMACOLOGY, 1998, 124 (01) :1-3
[3]  
BURNSTOCK G, 1972, PHARMACOL REV, V24, P509
[4]   Excitatory peptides and osmotic pressure modulate mechanosensitive cation channels in concert [J].
Chakfe, Y ;
Bourque, CW .
NATURE NEUROSCIENCE, 2000, 3 (06) :572-579
[5]   ATP MEDIATES AN EXCITATORY NORADRENERGIC NEURON INPUT TO SUPRAOPTIC VASOPRESSIN CELLS [J].
DAY, TA ;
SIBBALD, JR ;
KHANNA, S .
BRAIN RESEARCH, 1993, 607 (1-2) :341-344
[6]   EXCITATION OF SUPRAOPTIC VASOPRESSIN CELLS BY STIMULATION OF THE A1 NORADRENALINE CELL GROUP - FAILURE TO DEMONSTRATE ROLE FOR ESTABLISHED ADRENERGIC OR AMINO-ACID RECEPTORS [J].
DAY, TA ;
RENAUD, LP ;
SIBBALD, JR .
BRAIN RESEARCH, 1990, 516 (01) :91-98
[7]   Expression of inositol 1,4,5-trisphosphate receptors changes the Ca2+ signal of Xenopus oocytes [J].
DeLisle, S ;
Blondel, O ;
Longo, FJ ;
Schnabel, WE ;
Bell, GI ;
Welsh, MJ .
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 1996, 270 (04) :C1255-C1261
[8]   ROLE OF BLOOD OSMOLALITY AND VOLUME IN REGULATING VASOPRESSIN SECRETION IN RAT [J].
DUNN, FL ;
BRENNAN, TJ ;
NELSON, AE ;
ROBERTSON, GL .
JOURNAL OF CLINICAL INVESTIGATION, 1973, 52 (12) :3212-3219
[9]  
FREDHOLM BB, 1994, PHARMACOL REV, V46, P143
[10]  
GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440